Literature DB >> 31949687

The value of lymph node ratio in the prediction of rectal cancer patient survival after preoperative chemoradiotherapy.

Li Chen1, Xuefeng Huang1, Zhangfa Song1.   

Abstract

BACKGROUND: Although the absolute number of postoperative positive lymph nodes has been considered as one of the most important predictors for the survival of rectal cancer patients, many researchers have suggested that the lymph node ratio (LNR) may have a better predictive effect. After chemoradiotherapy for rectal cancer, the number of lymph nodes harvested is often reduced, and the predictive value of the postoperative LNR after chemoradiotherapy is still unclear. We performed a retrospective study to analyze the survival predictive value of the LNR after preoperative chemoradiotherapy for rectal cancer.
METHODS: Between January 2012 and December 2014, a total of 133 patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy followed by total mesorectal excision were reviewed. According to the postoperative pathological LNR, patients were divided into 3 groups, i.e., LNR = 0, 0 < LNR ≤ 0.15, and 0.15 < LNR ≤ 1, and patients with lymph node metastasis were divided into 2 groups, and the overall survival (OS) and disease-free survival (DFS) of each group were analyzed and evaluated.
RESULTS: The median follow-up time of this study was 40 months, and the 5-year OS and DFS rates were 86.3% and 74.8% for the whole cohort, respectively. According to the postoperative pathological LNR, patients were divided into 3 groups, LNR = 0, 0 < LNR ≤ 0.15, 0.15 < LNR ≤ 1, the respective 5-year OS and DFS rates for the LNR 3 groups were 96.7%, 94.7% and 42.9% (P < 0.001) and 84.9%, 73%, and 30.7% (P < 0.001), respectively. Multivariate analysis revealed that only the LNR was the independent prognostic factor for these patients. For patients with lymph node metastasis, it was also revealed that only the LNR was an independent prognostic factor. Subgroup analysis demonstrated that there was a significant correlation between the LNR and patient survival both in the number of lymph nodes harvested, less than 12 and more than 12 subgroups (P < 0.05).
CONCLUSION: The postoperative positive lymph node ratio (LNR) is an independent prognostic factor for patients with locally advanced rectal cancer who undergo preoperative chemoradiotherapy followed by total mesorectal excision. Both in the number of lymph nodes harvested less than 12 and more than 12 subgroups, the LNR is significantly correlated with patient survival. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Rectal cancer; chemoradiotherapy; lymph node

Year:  2018        PMID: 31949687      PMCID: PMC6963083     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

1.  Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection.

Authors:  S D Lee; T H Kim; D Y Kim; J Y Baek; S Y Kim; H J Chang; S C Park; J W Park; J H Oh; K H Jung
Journal:  Eur J Surg Oncol       Date:  2012-03-30       Impact factor: 4.424

2.  Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification.

Authors:  J W T Dekker; K C Peeters; H Putter; A L Vahrmeijer; C J H van de Velde
Journal:  Eur J Surg Oncol       Date:  2010-12       Impact factor: 4.424

3.  Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer.

Authors:  Junjie Peng; Ye Xu; Zuqing Guan; Ji Zhu; Minghe Wang; Guoxiang Cai; Weiqi Sheng; Sanjun Cai
Journal:  Ann Surg Oncol       Date:  2008-09-03       Impact factor: 5.344

4.  Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.

Authors:  Khaled M Madbouly; Khaled S Abbas; Ahmed M Hussein
Journal:  Am J Surg       Date:  2013-10-08       Impact factor: 2.565

5.  Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.

Authors:  Wei-Gen Zeng; Zhi-Xiang Zhou; Zheng Wang; Jian-Wei Liang; Hui-Rong Hou; Hai-Tao Zhou; Xing-Mao Zhang; Jun-Jie Hu
Journal:  Asian Pac J Cancer Prev       Date:  2014

6.  Impact of metastatic lymph node ratio in node-positive colorectal cancer.

Authors:  Shingo Noura; Masayuki Ohue; Shingo Kano; Tatsushi Shingai; Terumasa Yamada; Isao Miyashiro; Hiroaki Ohigashi; Masahiko Yano; Osamu Ishikawa
Journal:  World J Gastrointest Surg       Date:  2010-03-27

7.  Ratio of metastatic to resected lymph nodes as a prognostic factor in node-positive colorectal cancer.

Authors:  Jung Wook Huh; Young Jin Kim; Hyeong Rok Kim
Journal:  Ann Surg Oncol       Date:  2010-03-19       Impact factor: 5.344

8.  The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.

Authors:  Frédérique Peschaud; Peschaud Frédérique; Stéphane Benoist; Benoist Stéphane; Catherine Julié; Julié Catherine; Alain Beauchet; Beauchet Alain; Christophe Penna; Penna Christophe; Philippe Rougier; Rougier Philippe; Bernard Nordlinger
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

9.  Lymph node harvest in colon cancer: influence of microsatellite instability and proximal tumor location.

Authors:  Kjetil Søreide; Bjørn Steinar Nedrebø; Jon Arne Søreide; Aida Slewa; Hartwig Kørner
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

10.  Positive lymph node retrieval ratio optimises patient staging in colorectal cancer.

Authors:  S J Moug; J D Saldanha; J R McGregor; M Balsitis; R H Diament
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

View more
  3 in total

1.  Prognostic value of lymph node ratio in resectable rectal cancer after preoperative short-course radiotherapy-results from randomized clinical trial.

Authors:  Radoslaw Pach; Antoni M Szczepanik; Marek Sierzega; Michal Daniluk; Piotr Richter
Journal:  Langenbecks Arch Surg       Date:  2022-07-04       Impact factor: 3.445

Review 2.  Beyond N staging in colorectal cancer: Current approaches and future perspectives.

Authors:  Gianluca Arrichiello; Mario Pirozzi; Bianca Arianna Facchini; Sergio Facchini; Fernando Paragliola; Valeria Nacca; Antonella Nicastro; Maria Anna Canciello; Adele Orlando; Marianna Caterino; Davide Ciardiello; Carminia Maria Della Corte; Morena Fasano; Stefania Napolitano; Teresa Troiani; Fortunato Ciardiello; Giulia Martini; Erika Martinelli
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

3.  Lymph Node Ratio as a Prognostic Marker in Rectal Cancer Survival: A Systematic Review and Meta-Analysis.

Authors:  Uday Karjol; Pavan Jonnada; Ajay Chandranath; Sushma Cherukuru
Journal:  Cureus       Date:  2020-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.